Prospects for the immunotherapy of cancer. Part I: Basic concepts of tumor immunology.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000912:Antibodies, Neoplasm / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D002272:Carcinoembryonic Antigen; D002648:Child; D002675:Child, Preschool; D004267:DNA Viruses; D005260:Female; D006087:Graft vs Host Reaction; D006168:Guinea Pigs; D006801:Humans; D006968:Hypersensitivity, Delayed; D007106:Immune Sera / Q000032:analysis; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007167:Immunotherapy; D007223:Infant; D007231:Infant, Newborn; D008214:Lymphocytes / Q000502:physiology; D008297:Male; D008545:Melanoma / Q000276:immunology; D008875:Middle Aged; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000209:etiology / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology* / Q000382:microbiology; D009447:Neuroblastoma / Q000276:immunology; D009858:Oncogenic Viruses; D012328:RNA Viruses; D051381:Rats; D012509:Sarcoma / Q000276:immunology
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D007106:Immune Sera